Abstract

The presented work describes the thyroid pathologies and the nuclear-medical diagnostic approach, in order toobtain a differential diagnosis and the monitoring of various neoplasms; specifically, it describes the importance ofradiometabolic treatment with iodine 131, after thyroidectomy surgery.Through a study conducted in patients suffering from thyroid disease, undergoing metabolic radiotherapy, it is shownthat, with equal distribution of radioiodine, uptake with at least 3700 MBq of therapeutic dose is obtained. All thiscan be seen through the whole body scintigraphic framework, obtained through the use of the double-headed gammacamera with collimators for high emission energies.Radiometabolic treatment is effective in patients with a high risk of relapse, while radioiodine treatment is notrecommended in low-risk patients

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call